Pulse Biosciences (PLSE) Accumulated Expenses (2015 - 2026)

Pulse Biosciences' Accumulated Expenses history runs 11 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• In Q4 2025, Accumulated Expenses fell 71.84% year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at $2.0 million (down 71.84% YoY), while the FY2025 annual figure was $2.0 million, down 71.84% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $2.0 million, down from $4.0 million in the prior quarter.
• The five-year high for Accumulated Expenses was $7.0 million in Q4 2024, with the low at $1.4 million in Q4 2022.
• The 5-year median for Accumulated Expenses is $3.6 million (2021), against an average of $3.5 million.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses soared 176.98% in 2023, then tumbled 71.84% in 2025.
• Pulse Biosciences' Accumulated Expenses stood at $3.8 million in 2021, then slumped by 63.9% to $1.4 million in 2022, then surged by 176.98% to $3.8 million in 2023, then soared by 84.24% to $7.0 million in 2024, then sank by 71.84% to $2.0 million in 2025.
• Business Quant data shows PLSE's Accumulated Expenses at $2.0 million in Q4 2025, $4.0 million in Q1 2025, and $7.0 million in Q4 2024.